The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Richards, J. O.
Right arrow Articles by Lake, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Richards, J. O.
Right arrow Articles by Lake, D. F.
The Journal of Immunology, 2002, 169: 2020-2025.
Copyright © 2002 by The American Association of Immunologists

Reversal of Coccidioidal Anergy In Vitro by Dendritic Cells from Patients with Disseminated Coccidioidomycosis

John O. Richards*, Neil M. Ampel*,{dagger},{ddagger} and Douglas F. Lake1,*,§

* Department of Microbiology and Immunology, Arizona Health Sciences Center, Tucson, AZ 85724; Departments of {dagger} Medicine and {ddagger} Microbiology and Immunology, Southern Arizona Veterans Affairs Health Care System, Tucson, AZ 85723; and § Department of Microbiology and Immunology, Arizona Cancer Center, University of Arizona, Tucson, AZ 85724.

Coccidioides immitis is a pathogenic, dimorphic fungus found in the southwestern United States and is the causative agent of coccidioidomycosis. Extrathoracic dissemination of coccidioidomycosis is associated with a lack of cellular immunity. Dendritic cells (DCs) have been shown to initiate and modulate cellular immune responses. To determine whether DCs could modulate or initiate the immune response in this disease, monocyte-derived DCs were generated from coccidioidal Ag nonresponsive patients with disseminated coccidioidomycosis and healthy nonimmune individuals. DCs generated from both groups demonstrated phenotypes characteristic of DCs and stimulated strong allogeneic MLR. DCs from patients and healthy nonimmune individuals pulsed with the coccidioidal Ag preparation T27K induced lymphocyte proliferation. Mature DCs were much more efficient than immature DCs in these stimulations. Furthermore, restimulation of T27K-primed PBMC with Ag-pulsed DCs generated a C. immitis-specific cellular immune response in PBMC from patients with disseminated coccidioidomycosis as well as healthy nonimmune individuals. These results show that 1) DCs have the capacity to stimulate specific cellular immune responses from patients with disseminated coccidioidomycosis who are nonresponsive to coccidioidal Ag and healthy nonimmune individuals in vitro; 2) DCs can be used to screen coccidioidal Ags as candidates for human vaccine development; and 3) DC therapy may be useful in the treatment of disseminated coccidioidomycosis.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
S. O. Dionne, A. B. Podany, Y. W. Ruiz, N. M. Ampel, J. N. Galgiani, and D. F. Lake
Spherules Derived from Coccidioides posadasii Promote Human Dendritic Cell Maturation and Activation
Infect. Immun., April 1, 2006; 74(4): 2415 - 2422.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Awasthi, V. Awasthi, D. M. Magee, and J. J. Coalson
Efficacy of Antigen 2/Proline-Rich Antigen cDNA-Transfected Dendritic Cells in Immunization of Mice against Coccidioides posadasii
J. Immunol., September 15, 2005; 175(6): 3900 - 3906.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
N. M. Ampel, D. K. Nelson, S. Chavez, K. A. Naus, A. B. Herman, L. Li, K. A. Simmons, and D. Pappagianis
Preliminary Evaluation of Whole-Blood Gamma Interferon Release for Clinical Assessment of Cellular Immunity in Patients with Active Coccidioidomycosis
Clin. Vaccine Immunol., June 1, 2005; 12(6): 700 - 704.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
R. A. Cox and D. M. Magee
Coccidioidomycosis: Host Response and Vaccine Development
Clin. Microbiol. Rev., October 1, 2004; 17(4): 804 - 839.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.